Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04965766
Title Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer (ICARUS-BREAST)
Acronym ICARUS-BREAST
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Georges François Leclerc Dijon 21079 France Details
CHU de Limoges Limoges 87042 France Details
Centre Léon Bérard Lyon 69373 France Details
Institut Paoli Calmettes Marseille 13273 France Details
Institut Régional du Cancer de Montpellier Montpellier 34298 France Details
Centre Antoine Lacassagne Nice 06189 France Details
Institut Curie Paris 75005 France Details
Hôpital Tenon Paris 75020 France Details
Institut de Cancérologie de l'Ouest Saint-Herblain 44805 France Details
Institut Claudius Regaud Toulouse 31059 France Details
Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field